​

Protagenic Therapeutics Stock (NASDAQ:PTIX)

OwnershipFinancialsChart

Previous Close

$1.03

52W Range

$0.13 - $4.55

50D Avg

$0.46

200D Avg

$0.68

Market Cap

$1.67M

Avg Vol (3M)

$16.61K

Beta

1.07

Div Yield

-

PTIX Company Profile

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Apr 27, 2021

Website

PTIX Performance

PTIX Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-5.83M$-5.70M$-4.53M
Net Income$-5.16M$-5.53M$-5.00M
EBITDA$-8.02M$-5.47M$-4.50M
Basic EPS$-3.45$-1.13$-1.15
Diluted EPS$-3.45$-1.13$-1.15

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 23Apr 01, 24 | 4:30 PM

Peer Comparison

TickerCompany
ARTLArtelo Biosciences, Inc.
PBMPsyence Biomedical Ltd.
GTBPGT Biopharma, Inc.
INDPIndaptus Therapeutics, Inc.
REVBRevelation Biosciences, Inc.
SLXNSilexion Therapeutics Ltd.
SPRCSciSparc Ltd.
CARMCarisma Therapeutics, Inc.